ライフサイエンスコーパス: premenstrual dysphoric disorder

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ission in the efficacy of SSRI treatment for premenstrual dysphoric disorder.

2 in reuptake inhibitors (SSRIs) in women with premenstrual dysphoric disorder.

3 fective for severe premenstrual syndrome and premenstrual dysphoric disorder.

4 ction may be involved in the pathogenesis of premenstrual dysphoric disorder.

5 disorders, such as postpartum depression and premenstrual dysphoric disorder.

6 ical link between subtypes of depressive and premenstrual dysphoric disorders.

7 acebo-controlled protocol to nine women with premenstrual dysphoric disorder and 11 healthy female vo

8 a GABA levels were measured in 27 women with premenstrual dysphoric disorder and 21 comparison women

9 Women with premenstrual dysphoric disorder and a past history of ma

10 order, 21 with major depression, and 10 with premenstrual dysphoric disorder and in 34 normal compari

11 roup of experts to examine the literature on premenstrual dysphoric disorder and provide recommendati

12 equested participation, 243 met criteria for premenstrual dysphoric disorder and were randomized; 200

13 nic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder, and social phobia.

14 Premenstrual dysphoric disorder appears to be associated

15 tients with panic disorder and patients with premenstrual dysphoric disorder are highly susceptible t

16 In women with premenstrual dysphoric disorder but no past major depres

17 the hypothesis of serotonergic deficiency in premenstrual dysphoric disorder by measuring the prolact

18 The patients with premenstrual dysphoric disorder experienced a return of

19 pared to the normal subjects, the women with premenstrual dysphoric disorder had a significantly blun

20 e whether efficacy for premenstrual syndrome/premenstrual dysphoric disorder is a general or more ser

21 Premenstrual dysphoric disorder is an important cause of

22 Premenstrual dysphoric disorder is often associated with

23 e disorder and a state-dependent decrease in premenstrual dysphoric disorder might imply a possible c

24 id metabolite allopregnanolone in women with premenstrual dysphoric disorder (PMDD) and in asymptomat

25 strual cycle in healthy women and those with premenstrual dysphoric disorder (PMDD) and that a menstr

26 Despite evidence for the validity of premenstrual dysphoric disorder (PMDD) and the inclusion

27 There is substantial information that premenstrual dysphoric disorder (PMDD) is a clinically s

28 other psychiatric illnesses tested, although premenstrual dysphoric disorder (PMDD) may be an excepti

29 Premenstrual dysphoric disorder (PMDD) symptoms are elim

30 bitors (SRIs) are efficacious treatments for premenstrual dysphoric disorder (PMDD) when given daily

31 uggests that mood and behavioral symptoms in premenstrual dysphoric disorder (PMDD), a common, recent

32 h catamenial epilepsy and enhance anxiety in premenstrual dysphoric disorder (PMDD).

33 ; most of these women also meet criteria for premenstrual dysphoric disorder (PMDD).

34 ents with major depression and patients with premenstrual dysphoric disorder, respectively).

35 The panic rate for patients with premenstrual dysphoric disorder was similar to that for

36 Premenstrual dysphoric disorder, which affects 2%-5% of

37 Patients with premenstrual dysphoric disorder (whose symptoms had remi

38 thors sought to determine whether women with premenstrual dysphoric disorder with or without prior ma

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。